Intrabio
The startup develops small-molecule therapies that modulate lysosomal function and intracellular calcium signaling to treat rare and neurodegenerative diseases. These therapies aim to enhance patient outcomes and improve the quality of life for patients, caregivers, and families affected by these conditions.
Traction –/10
Austin, United States · HQ
- Biotechnology
Updated 5 months ago
Funding
Raised to date
$65.6MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops small-molecule therapies that modulate lysosomal function and intracellular calcium signaling to treat rare and neurodegenerative diseases. These therapies aim to enhance patient outcomes and improve the quality of life for patients, caregivers, and families affected by these conditions.